Pacira BioSciences, Inc. (PCRX) のトレーリングPERは 142.0, 予想PER 9.0. トレーリング益回りは 0.70%, 予想益回り 11.11%. PEG 0.01 (Peter Lynch 割安基準 ≤1.0). グレアム数は $7.79.
このページで証明された基準:
SharesGrow 総合スコア： 45/100 0/7 項目が合格。
| Year | P/E (TTM) | PEG レシオ | P/B レシオ | P/S レシオ | 配当利回り |
|---|---|---|---|---|---|
| 2016 | -31.7 | 0.01 | 5.49 | 4.35 | - |
| 2017 | -42.6 | -8.70 | 6.50 | 6.34 | - |
| 2018 | -3,736.7 | 37.77 | 5.48 | 5.22 | - |
| 2019 | -170.7 | -0.08 | 5.30 | 4.47 | - |
| 2020 | 17.5 | -0.01 | 4.12 | 5.94 | - |
| 2021 | 63.4 | -0.88 | 3.65 | 4.92 | - |
| 2022 | 110.5 | -1.75 | 2.27 | 2.64 | - |
| 2023 | 37.2 | 0.23 | 1.79 | 2.31 | - |
| 2024 | -8.8 | 0.03 | 1.12 | 1.24 | - |
| 2025 | 164.0 | -1.53 | 1.66 | 1.59 | - |
| Year | EPS（希薄化後） | 売上高 | 純利益 | 純利益率 |
|---|---|---|---|---|
| 2016 | $-1.02 | $276.37M | $-37.95M | -13.7% |
| 2017 | $-1.07 | $286.63M | $-42.61M | -14.9% |
| 2018 | $-0.01 | $337.28M | $-471K | -0.1% |
| 2019 | $-0.27 | $421.03M | $-11.02M | -2.6% |
| 2020 | $3.33 | $420.83M | $145.52M | 34.6% |
| 2021 | $0.92 | $541.53M | $41.98M | 7.8% |
| 2022 | $0.34 | $666.82M | $15.91M | 2.4% |
| 2023 | $0.81 | $674.98M | $41.96M | 6.2% |
| 2024 | $-2.15 | $700.97M | $-99.56M | -14.2% |
| 2025 | $0.16 | $726.41M | $7.03M | 1% |
| Year | EPS（平均） | EPS レンジ | 売上高（平均） | 売上高レンジ | アナリスト数 |
|---|---|---|---|---|---|
| 2026 | $2.65 | $2.30 – $2.97 | $761.73M | $761.33M – $762.13M | 4 |
| 2027 | $3.49 | $2.61 – $3.93 | $830.51M | $823.4M – $844.47M | 4 |
| 2028 | $4.77 | $4.70 – $4.88 | $960.98M | $954.22M – $967.74M | 3 |
| 2029 | $4.60 | $4.53 – $4.71 | $924.91M | $913.57M – $941.38M | 2 |
| 2030 | $4.95 | $4.87 – $5.06 | $935.3M | $923.84M – $951.96M | 2 |
